1.Influence of Yishen-Huoxue-Huatan capsule on the level of serum lipids, plasma endothelin (ET) and nitric oxide(NO) in patients with carotid atherosclerosis
International Journal of Traditional Chinese Medicine 2012;34(9):788-790
ObjectiveTo observe the effects of Yishen-Huoxue-Huatan capsule on carotid artery intima-media thickness (IMT),carotid atherosclerosis plaque area and the level of serum lipids,plasma endothelin (ET) and nitric oxide (NO) in patients with carotid atherosclerosis.Methods126 patients with carotid atherosclerotic were randomly assigned to treatment group and control group.Patients in treatment group was treated by yishen huoxue huatan capsule,and patients in control group was treated by zocor.Each patient was treated for 24 weeks.ResultsAfter the treatment,carotid IMT [respectively (0.81±0.11)mm,(1.10± 0.27)mm],atherosclerotic plaque area [respectively (11.21 ± 9.3)mm2,(16.53± 6.9)mm2] in both the treatment group and the control group were significantly lower compared with the same group before treatment (P<0.05),and the treatment group was better than the control group (P<0.05); serum cholesterol (TC),respectively [ (4.51 ± 0.37) mmol/L,(5.15 ± 0.20) mmol/L],triglyceride (TG) [respectively ( 1.77± 0.09) mmol/L,(1.79 ± 0.36) mmol/L],high-density lipoprotein cholesterol (HDL-C) [respectively (1.28 ± 0.26) mmol/L,(1.27 ±0.36) mmol/L],low-density lipoprotein cholesterol (LDL-C) [ (2.50± 0.30) mmol/L,(3.10± 0.39) mmol/L] in the treatment group and the control group were improved significantly (P<0.05) compared with the same group before treatment,and the TC and LDL-C levels in the treatment group were significantly lower than the control group (P<0.05); plasma ET [respectively (67.26± 14.13) ng/L,(79.38± 11.54)ng/L] NO [respectively (71.65± 111.64)μmol / L,(60.64±14.02)μmol/L] in the treatment group and the control group were higher than those in the same group before treatment (P<0.05),and the plasma ET levels in the treatment group was significantly lower than the control group (P<0.05),while the plasma NO level was significantly higher(P< 0.05).ConclusionYishen-Huoxue-Huatan capsule is effective in the treatment of carotid atheroselerosis.
2.Prevention and management of hemorrhage during laparoscopic cholecystectomy
Chinese Journal of Primary Medicine and Pharmacy 2010;17(6):727-728
ObjectiveTo investigate the prevention and management of the hemorrhage during laparoscopic cholecystectomy( LC), and improve success ratio. MethodsThe medical data of 420 cases with LC from May 2003 to 2009, September were analyzed retrospectively, including total number, hemorrhage site and ways of prevention and management. Results417 cases experienced successful C,with success ratio 99.3%. 49 cases ( 11.7% ) had hemorrhage, and in 46 cases(93. 9% ), it was stopped by laparoscope or hemostasis by compression,3 cases were rescued by operation. All hemorrhage sites included 15 cases(30. 6% ) in triangle de Calot,26 cases(53. 1% ) in gallbladder bed, and 8 cases ( 16.3% ) in incision. ConclusionA reliable opetration and appropriate hemostasis are critical of the successful operation and prevention of complications after LC.
3.Secondary development strategy of Chinese materia medica enterprises in China
Chinese Traditional and Herbal Drugs 1994;0(02):-
Developing along with the chemicals to tend gradually hard and adopting the natural medicine to rise,the international pharmacy field interesting in Chinese materia medica(CMM) increases gradually.The exterior competition of the CMM enterprises is becoming drastic and the secondary deve-(lopment) of CMM for the medicine enterprises in our country should be a better choose to face the international medicine market competition.The internal and external process about the secondary development of CMM should be taken into account and the strategy that should be adopted in the secondary development put forward.Such as: secendary development of new medicine of the CMM compound recipe;turning deeply to the CMM foundation research;the importance of developing the safe and valid CMM whose qua-(lity) is stabile and controlled;the importance of rising the processing level of the product,etc.It emphasized the importance in appling modern science and technology in the text.
4.Resistant starch and metabolic syndrome
Parenteral & Enteral Nutrition 1997;0(04):-
Resistant starch is not absorbed in the small intestine.But it can be fermented in the large bowel.Recent studies have confirmed the ability of resistant starch to decrease postprandial blood glucose levels,decrease serum cholesterol and triglyeride levels,and enhance the sensitivity of insulin.As such,resistant starch contributes to preventing and treating metabolic syndrome.
5.Preliminary Study on Flare-Prediction in Patients with Systemic Lupus Erythematosus
Chinese Journal of Dermatology 1995;0(01):-
Objective To study the value of routine laboratory examinations, symptoms and soluble IL-2 receptor (sIL-2R) in the flare-prediction on systemic lupus erythematosus(SLE). Methods A prospective study was performed in 106 outpatients with SLE and the patients′ conditions were assessed according to Systemic Lupus Erythematosus Disease Activity Index(SLEDAI). Patients were asked to visit at no longer than 3-month interval. All patients were followed-up for 6 to 18 months. At each visit, laboratory examinations, symptoms, disease activity, as well as the changes in the treatment were recorded according to the protocol. The values of these parameters in flare-prediction were comprehensively assessed based on their frequency and time respectively when they became abnormal before the disease flare. Results Among the 106 patients, the disease activity of 67 cases were in remission and satisfied the prospective study criteria of the SLE flare. Thirty-one flares in 29 patients were observed. The frequency of flare was 0.44/patient/year. Comprehensively the most valuable predictor of those parameters was anti-dsDNA antibody, followed by complement components, sIL-2R, erythrocyte sedimentation rate(ESR), complete blood count, urine analysis, fatigue, mucous membrane ulceration, new rashes and alopecia. C3 was a better predictor for SLE flares than that of C4 and CH50. Conclusions The flares of SLE could be predicted. Early intervention will help to prevent patients from flare.
8.Keeping pace with time enrichment of pathologic information.
Chinese Journal of Pathology 2008;37(2):73-74
Delivery of Health Care
;
legislation & jurisprudence
;
methods
;
Female
;
Forecasting
;
Health Services for the Aged
;
legislation & jurisprudence
;
supply & distribution
;
Humans
;
Male
;
Medical Informatics
;
Prostatic Intraepithelial Neoplasia
;
pathology
;
Prostatic Neoplasms
;
pathology
;
Time Factors
9.Paying attention to the correct application of non-steroidal anti-inflammatory drugs in the treatment of ocular surface inflammatory disease
Ming-chang, ZHANG ; Jie, ZHANG
Chinese Journal of Experimental Ophthalmology 2013;32(11):1001-1002
Inflammation is a common ocular surface disease.Glucocorticoid drugs are effective on the ocular surface inflammation,but their long-term and massive application is prone to serious side effects.Nonsteroidal antiinflammatory drugs (NSAIDs) have anti-inflammatory,anti-allergic,analgesic effects.The topical application of NSAIDs for the prevention and treatment of ocular inflammatory disease is much safer than that of glucocorticoid.Therefore,NSAIDs have more and more concerns in the treatment of ocular surface inflammation in recent years.Although NSAID has good anti-inflammatory effectiveness and less adverse effects,it should be correctly administered.During the treatment process of inflammatory ocular surface diseases,the combination of NSAIDs with glucocorticoid drug can strengthen the curative effect and reduce the adverse reactions.
10. Proliferation inhibition and apoptosis induction of cucurmosin on human pancreatic cancer CFPAC-1 cells
Chinese Pharmaceutical Journal 2012;47(12):956-959
OBJECTIVE: To investigate the mechanism that cucurmosin (CUS) induces the apoptosis of human pancreatic cancer cell line CFPAC-1. METHODS: The inhibition effect of cucurmosin on CFPAC-1 cell was detected by MTT assay. The apoptosis was observed by transmission electron microscope. The cell cycle and apoptosis rate were analyzed by flow cytometry. The expressions of caspase-3 and bcl-2 protein were determined by Westernblot. RESULTS: After CFPAC-1 cells were treated with cucurmosin of 0.03125, 0.0625,0.125,0.25,0.5, 1 and 2 μmol · L-1 for 24,48 and 72 h, the proliferation of CFPAC-1 cells was inhibited in a time- and dose- dependent manner(P<0.05). After CFPAC-1 cells were treated with 1 μmol · L-1 cucurmosin for 72 h, typical apoptosis changes were observed under transmission electron microscope. Compared with control group, more cells were arrested at G0/G1 phases (P<0.05) and fewer cells were at S phases(P<0.05). CUS decreased the speed of cell-cycle progression from G0/G1 phase into S phase. After CFPAC-1 cells were treated without(control) or with cucurmosin of 0.062 5,0.25 and 1 μmol · L-1 for 72 h, the apoptosis rates of CFPAC-1 cells were (0.33±0.37)%, (19.26±1.49)%,(37.13±2.07)% and (55.64±2.91)%, respectively. The expression of caspase-3 was elevated, whereas the expression of Bcl-2 was lessened gradually. CONCLUSION: Cucurmosin induces the apoptosis of pancreatic cancer CFPAC-1 cells through up-regulating the expression of caspase-3 and down-regulating the expression of bcl-2.